Chronic News and Research

RSS

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

A recent observational study in Israel evaluates the efficacy of a Pfizer vaccine booster dose in reducing the mortality rate of COVID-19.

12 Dec 2021

Clinical studies show enhanced responses for lymphoma patients treated with axi-cel CAR T cell therapy

Three clinical studies led by researchers at The University of Texas MD Anderson Cancer Center demonstrated enhanced responses for patients with high-risk lymphoma treated with axicabtagene ciloleucel (axi-cel) chimeric antigen receptor (CAR) T cell therapy.

12 Dec 2021

Novel AI score predicts risk of death in patients with suspected or known coronary artery disease

A novel artificial intelligence score provides a more accurate forecast of the likelihood of patients with suspected or known coronary artery disease dying within 10 years than established scores used by health professionals worldwide.

11 Dec 2021

UTSW study points to a new way to fight parasitic nematode diseases

Combining two agents to block a parasitic worm's life cycle boosted survival from a potentially deadly tropical disease to 85% in animal models, far better than either treatment alone, according to a proof-of-concept study led by UT Southwestern Medical Center pharmacologists.

11 Dec 2021

Potentially serious side effect reported after CAR-T cell therapy for multiple myeloma

Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell therapy, which was recently approved for the treatment of multiple myeloma.

11 Dec 2021

A rural Georgia community reels after its hospital closes

Lacandie Gipson struggled to breathe. The 33-year-old woman with multiple health conditions was in respiratory distress and awaiting an ambulance. About 20 minutes after the emergency call, it arrived.

10 Dec 2021

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

Researchers published a report wherein they assessed the symptomology post a booster dose of mRNA vaccines in adults with IBD.

10 Dec 2021

New research analyzes inequities and health impacts of flooding

Flooding is the most expensive natural disaster in the United States, according to the National Oceanic and Atmospheric Administration (NOAA), costing the country more than $1 trillion in inflation-adjusted dollars since 1980.

9 Dec 2021

Regular aerobic exercise during midlife may prevent age-related chronic diseases

Middle-aged endurance athletes have better control of blood pressure and higher arterial elasticity (a noninvasive measure of cardiovascular risk) than sedentary adults in the same age group.

9 Dec 2021

Adverse childhood experiences increase young adults' risk of opioid misuse

Young adults who experienced trauma in childhood are more at risk for misusing prescription opioids, according to new research from the University of Georgia.

9 Dec 2021

CDC encourages 16-and-17-year-old adolescents to receive COVID-19 booster shot

Today, CDC is strengthening its booster recommendations and encouraging everyone 16 and older to receive a booster shot. Although we don't have all the answers on the Omicron variant, initial data suggests that COVID-19 boosters help broaden and strengthen the protection against Omicron and other variants.

9 Dec 2021

Study of individuals referred to a cardiovascular disease clinic designed for patients with long COVID

Scientists discuss the characteristics, diagnostic evaluations, and cardiac diagnoses in patients referred to a clinic designed for patients with PASC.

9 Dec 2021

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11.

9 Dec 2021

Chronic News and Research

Efficacy of BNT162b2 vaccine booster in reducing mortality due to COVID-19

Clinical studies show enhanced responses for lymphoma patients treated with axi-cel CAR T cell therapy

Novel AI score predicts risk of death in patients with suspected or known coronary artery disease

UTSW study points to a new way to fight parasitic nematode diseases

Potentially serious side effect reported after CAR-T cell therapy for multiple myeloma

A rural Georgia community reels after its hospital closes

Symptoms after a third mRNA vaccine among patients with inflammatory bowel disease

New research analyzes inequities and health impacts of flooding

Regular aerobic exercise during midlife may prevent age-related chronic diseases

Adverse childhood experiences increase young adults' risk of opioid misuse

CDC encourages 16-and-17-year-old adolescents to receive COVID-19 booster shot

Study of individuals referred to a cardiovascular disease clinic designed for patients with long COVID

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

Youths did not seek healthcare both before and during the COVID-19 pandemic

New report provides data on the wellbeing of working-age Australians with chronic conditions

UVA researchers uncover common link between lupus and macular degeneration

Study uncovers differences in one-carbon and energy metabolism between episodic, chronic depression

High-dose intravenous iron reduces heart attacks in hemodialysis patients

Research provides new insights into debilitating cluster headaches

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News